Mason & Associates Inc Makes New Investment in Oscar Health, Inc. $OSCR

Mason & Associates Inc bought a new stake in shares of Oscar Health, Inc. (NYSE:OSCR) in the third quarter, Holdings Channel reports. The fund bought 38,128 shares of the company’s stock, valued at approximately $722,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Thrive Capital Management LLC boosted its stake in shares of Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after acquiring an additional 1,588,395 shares during the last quarter. State of Michigan Retirement System acquired a new position in Oscar Health in the 3rd quarter valued at $27,448,000. Jump Financial LLC lifted its holdings in Oscar Health by 798.3% in the 2nd quarter. Jump Financial LLC now owns 1,441,506 shares of the company’s stock valued at $30,906,000 after purchasing an additional 1,281,032 shares in the last quarter. Bienville Capital Management LLC acquired a new stake in Oscar Health during the 2nd quarter worth $21,204,000. Finally, American Century Companies Inc. boosted its stake in Oscar Health by 45.4% during the 2nd quarter. American Century Companies Inc. now owns 2,802,649 shares of the company’s stock worth $60,089,000 after purchasing an additional 875,388 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Stock Performance

Oscar Health stock opened at $13.41 on Friday. The firm has a 50 day simple moving average of $15.24 and a 200-day simple moving average of $16.69. The stock has a market cap of $3.55 billion, a price-to-earnings ratio of -7.70 and a beta of 1.90. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.92 and a quick ratio of 0.92. Oscar Health, Inc. has a 1-year low of $11.20 and a 1-year high of $23.80.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Tuesday, February 10th. The company reported ($1.24) EPS for the quarter, missing the consensus estimate of ($0.92) by ($0.32). The firm had revenue of $2.76 billion for the quarter, compared to analysts’ expectations of $3.12 billion. Oscar Health had a negative net margin of 3.79% and a negative return on equity of 37.72%. The firm’s quarterly revenue was up 17.3% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.62) EPS. On average, analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current year.

Insiders Place Their Bets

In related news, insider Mario Schlosser sold 76,962 shares of the business’s stock in a transaction dated Tuesday, January 6th. The shares were sold at an average price of $17.01, for a total value of $1,309,123.62. Following the sale, the insider directly owned 350,180 shares in the company, valued at approximately $5,956,561.80. The trade was a 18.02% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Adam Mcananey sold 1,852 shares of the stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total transaction of $30,724.68. Following the transaction, the insider directly owned 179,241 shares of the company’s stock, valued at $2,973,608.19. The trade was a 1.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 197,125 shares of company stock worth $3,265,300. Company insiders own 24.39% of the company’s stock.

Analysts Set New Price Targets

OSCR has been the subject of a number of recent research reports. Weiss Ratings reiterated a “sell (d)” rating on shares of Oscar Health in a research report on Thursday, January 22nd. UBS Group reaffirmed a “neutral” rating and set a $15.00 price objective on shares of Oscar Health in a research note on Wednesday. Wells Fargo & Company decreased their target price on shares of Oscar Health from $14.00 to $11.00 and set an “underweight” rating on the stock in a research note on Thursday, November 13th. Barclays set a $18.00 target price on Oscar Health and gave the stock an “equal weight” rating in a report on Monday, January 5th. Finally, Piper Sandler raised Oscar Health from a “neutral” rating to an “overweight” rating and increased their price target for the company from $13.00 to $25.00 in a report on Tuesday, November 25th. Two equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $16.88.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.